The addition of lopinavir-ritonavir to carfilzomib-based triplets can induce meaningful clinical response in carfilzomib-refractory myeloma patients: a single-center experience.

Bennett, Rory; Chan, Henry; Henderson, Ross; Merriman, Eileen; Hanna, Merit; Elinder-Camburn, Anna; Simpson, David

Bennett, Rory; Chan, Henry; Henderson, Ross; Merriman, Eileen; Hanna, Merit; Elinder-Camburn, Anna; Simpson, David.

Afiliação

Bennett R; Department of Haematology, Waitemata District Health Board, Takapuna, New Zealand.
Chan H; Department of Haematology, Waitemata District Health Board, Takapuna, New Zealand.
Henderson R; Faculty of Medical and Health Sciences, The University of Auckland, Grafton, New Zealand.
Merriman E; Department of Haematology, Waitemata District Health Board, Takapuna, New Zealand.
Hanna M; Department of Haematology, Waitemata District Health Board, Takapuna, New Zealand.
Elinder-Camburn A; Faculty of Medical and Health Sciences, The University of Auckland, Grafton, New Zealand.
Simpson D; Department of Haematology, Waitemata District Health Board, Takapuna, New Zealand.

Leuk Lymphoma ; 63(7): 1738-1741, 2022 07.

Article em En | MEDLINE | ID: mdl-35147474

Assuntos

Mieloma Múltiplo; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos; Dexametasona/uso terapêutico; Humanos; Lopinavir/uso terapêutico; Mieloma Múltiplo/diagnóstico; Mieloma Múltiplo/tratamento farmacológico; Recidiva Local de Neoplasia/tratamento farmacológico; Oligopeptídeos; Ritonavir/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google